يعرض 1 - 20 نتائج من 289 نتيجة بحث عن '"Anticoagulantes orales"', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المؤلفون: Ferré Rey, Josep

    المساهمون: University/Department: Universitat Rovira i Virgili. Departament de Medicina i Cirurgia

    Thesis Advisors: Bladé Creixenti, Jordi, Piñol Moreso, Josep LLuís

    المصدر: TDX (Tesis Doctorals en Xarxa)

    Time: 616.1

    وصف الملف: application/pdf

  2. 2
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
    Academic Journal

    المصدر: RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; Vol. 5 No. 5 (2024): CLICK HERE TO ACCESS THE ARTICLES; e555203 ; RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; Vol. 5 Núm. 5 (2024): HAGA CLIC AQUÍ PARA ACCEDER A LOS ARTÍCULOS; e555203 ; RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; v. 5 n. 5 (2024): CLIQUE AQUI PARA ACESSAR OS ARTIGOS; e555203 ; RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218; Vol. 5 N.º 5 (2024): CLIQUE AQUI PARA ACESSAR OS ARTIGOS; e555203 ; 2675-6218

    وصف الملف: application/pdf

  7. 7
    Academic Journal

    المساهمون: Facultad de Ciencias Medicas de Bayamo

    المصدر: MULTIMED; Vol. 28 (2024): Publicación Continua; e2941 ; 1028-4818

    وصف الملف: application/pdf; application/xml

    Relation: https://revmultimed.sld.cu/index.php/mtm/article/view/2941/2704; https://revmultimed.sld.cu/index.php/mtm/article/view/2941/2705; Perreault S, de Denus S, White-Guay B, Côté R, Schnitzer ME, Dubé MP, et al. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation. Pharmacotherapy. 2020 Jan; 40(1):40-54.; Rodríguez Rocha WA. Factores asociados con la adherencia al tratamiento anticoagulante oral de pacientes con fibrilación auricular no valvular mayores de 65 años. [Tesis]. Bucaramanga: Universidad Autónoma de Bucaramanga; 2020. [citado 2/02/2024]. Disponible en: https://repository.unab.edu.co/bitstream/handle/20.500.12749/7196/2020_Tesis_Wiston_%20Alberto_Rodriguez_Rocha.pdf?sequence=1&isAllowed=y; Hwang J, Han S, Bae HJ, Jun SW, Choi SW, Lee CH, et al. NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters? Thromb Haemost. 2020; 120(2):306-13.; Yao RJ, Hawkins NM, Lavaie Y, Deyell MW, Andrade JG, Bashir JJ. Anticoagulation management of postoperative atrial fibrillation after cardiac surgery: A systematic review. Card Surg. 2021 Jun; 36(6):2081-94.; David Iglesias C, García Martín S, Casas Sepúlveda RM, Martín Ballesteros CP, Villarín Castro A. Cumplimiento terapéutico en pacientes en tratamiento con anticoagulantes orales en Atención Primaria. Rev Clin Med Fam. 2021; 14(1):12-7.; Yamashiro K, Kurita N, Tanaka R, Ueno Y, Miyamoto N, Hira K, et al. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2019 Jun; 28(6):1773-80.; Brízido C, Ferreira AM, Lopes P, Strong C, Sá Mendes G, Fernandes Gama F, et al. Adesão à terapêutica com anticoagulantes diretos em doentes comfibrilhação auricular não valvular – uma análise de mundo real. Rev Port Cardiol. 2021;40(9):669-75.; Bartolazzi F, Ribeiro Pinho AL, Frutos Nunes de Sosa WJ, Vianna MS, Padilha da Silva JL, Martins Perreiras MA. Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study. J Thromb Thrombolysis. 2021 Nov;52(4):1074-80.; Chen N, Brooks MM, Hernandez I. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients with a New Diagnosis of Atrial Fibrillation. JAMA Netw Open. 2020;3(2): e1921357.; Gumbinger C, Holstein T, Stock C, Rizos T, Horstmann S, Veltkamp R. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation. Eur Neurol. 2015; 73(3-4):184-91.; Emren SV, Şenöz O, Bilgin M, Beton O, Aslan A, Taşkin U, et al. Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR. Clin Appl Thromb Hemost. 2018 Apr;24(3):525-31.; Salmasi S, Loewen PS, Tandun R, Andrade JG, De Vera MA. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open. 2020;10(4): e034778.; Dod Santos Oliveira SH, Marquez de Sousa M, Muniz da Silva Bezerra SM, Silva T, da Sá Gomes KK, de Carvalho e Silva GC. Crenças relacionadas à adesão a dieta de pacientes tratados com anticoagulantes orais. Rev Gaúcha Enferm. 2019; 40: e20190083.; Al-Saikhan FI. Warfarin therapy adherence and health-related quality of life among patients using warfarin in Saudi Arabia. Niger J Clin Pract. 2020 Mar; 23(3):398-407.; Din N, Fan J, Schmitt S, Guo JD, Hlavacek P, Pundi K, et al. Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration. Clin Appl Thromb Hemost. 2023; 9:10760296231152474.; Batra G, Modica A, Renlund H, Larsson A, Christersson C, Held C. Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease. Open Heart. 2022;9(2): e002043.; Rubio-Armendáriz C, Alberto-Armas D, Plasín-Rodríguez MG, Padrón-Fuentes CC, Casanova-Herrera NR, González-González MY. Acenocumarol: uso, adherencia y conocimiento del usuario. Oportunidades para la Atención Farmacéutica. JONNPR. 2021; 6(12):1427-45.; Remigio Figueiredo T, Braz Costa CR, Barros Melo da Silveira MM, Soares de Araújo HV, Silva T, Muniz da Silva Bezerra SM. Adesão farmacológica e conhecimento de pacientes anticoagulados. Av. Enferm. 2018; 36(2):143-52.; https://revmultimed.sld.cu/index.php/mtm/article/view/2941

  8. 8
    Academic Journal
  9. 9
  10. 10
    Academic Journal
  11. 11
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal

    المساهمون: Reiban Espinoz, Esteban Adrián, 0105502611

    المصدر: Universidad Católica de Cuenca ; Repositorio Institucional - UCACUE

    Time: Cuenca - Ecuador

    وصف الملف: application/pdf; 20 páginas

    Relation: Andrade MNA, Espinoza EAR, Ortiz KSC, Di Rosa RR, Vivar MAC, Caraguay SAV, Sanmartín FAM, Lanzarin ALB. Uso de los nuevos anticoagulantes orales en el síndrome antifosfolipidico: revisión bibliográfica. Braz. J. Hea. Rev. [Internet]. 2023 Feb. 23 [cited 2024 Apr. 8];6(1):4103-22. Available from: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/57504; https://doi.org/10.34119/bjhrv6n1-319; Brazilian Journal of Health Review; 9BT2023-MTI282; https://dspace.ucacue.edu.ec/handle/ucacue/17181

  15. 15
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal

    المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 42 (2023) ; 1561-3011 ; 0864-0300

    وصف الملف: application/pdf

    Relation: https://revibiomedica.sld.cu/index.php/ibi/article/view/2353/1218; Bensi C, Belli S, Paradiso D, Lomurno G. Postoperative bleeding risk of direct oral anticoagulant safter oral surgery procedures: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2018;47(7):923-32. DOI: https://doi.org/10.1016/j.ijom.2018.03.016 2. Ockerman A, Miclotte I, Vanhaverbeke M, Vanassche T, Belmans A, Vanhove J, et al. Tranexamic acid and bleeding in patients treated with non-vitaminK oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial. PLoS Med. 2021;18(5):e1003601. DOI: https://doi.org/10.1371/journal.pmed.1003601 3. Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, et al. Updated European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17(10):1467-507. DOI: https://doi.org/10.1093/europace/euv309 4. Elad S, Marshall J, Meyerowitz C, Connolly G. Novel anticoagulants: general overview considerations for dental practitioners. Oral Dis. 2016;22(1):23-32. DOI: https://doi.org/10.1111/odi.12371 5. Caliskan M, Tükel H-C, Benlidayi M-E, Deniz A. Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants? Med Oral Patol Oral Cir Bucal. 2017;22(6):e767-73. DOI: https://doi.org/10.4317/medoral.21942 6. Morimoto Y, Yokoe C, Imai Y, Sugihara M, Futatsuki T. Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants. J Dent Sci. 2016;11(1):59-64. DOI: https://doi.org/10.1016/j.jds.2015.09.002 7. Andrade M, Andrade L, Bispo AF, Freitas LA, Feitosa GS, Feitosa-Filho GS. Evaluation of the bleeding intensity of patient’s anticoagulated with warfarin or dabigatran undergoing dental procedures. Arq Bras Cardiol. 2018;111(3):394-9. DOI: https://doi.org/10.5935%2Fabc.20180137 8. Galletti G, Alfonsi F, Ra A Valente, Chatelain S, Kolerman R, Cinquini CH, et al. Implant placement in patients under treatment with rivaroxaban: a retrospective clinical study. Int J Environ Res Public Health. 2020;17(12):4607. DOI: https://doi.org/10.3390%2Fijerph17124607; https://revibiomedica.sld.cu/index.php/ibi/article/view/2353

  19. 19
    Academic Journal

    المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 29, No. 2 (2023): Abril-Junio; e1391 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 29, No. 2 (2023): Abril-Junio; e1391 ; 1561-2937

    وصف الملف: application/pdf

    Relation: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1391/pdf; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1391/1174; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1391/1175; Westerman S, Wenger N. Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes. Curr Cardiol Rev. 2019 [acceso 15/05/2022];15(2):136-44. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30516110; Doñate Puertas R, Arora R, Rome S, Asatryan B, Roderick HL, Chevalier P. Epigenetics in atrial fibrillation: A reappraisal. Hear Rhythm. 2021;18(5):824-32. DOI: https://doi.org/10.1016/j.hrthm.2021.01.007; Di Carlo A, Zaninelli A, Mori F, Consoli D, Bellino L, Baldereschi M, et al. Prevalence of Atrial Fibrillation Subtypes in Italy and Projections to 2060 for Italy and Europe. J Am Geriatr Soc. 2020;68(11):2534-41. DOI: https://doi.org/10.1111/jgs.16748; Li D, Nie J, Han Y, Ni L. Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation. Front Cardiovasc Med. 2022;21(8):763-824. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35127848; González-Hermosillo JA, Márquez MF, Ocampo-Peña S. Diseño de un registro de fibrilación auricular y riesgo embólico en México: CARMEN-AF. Arch Cardiol México. 2017;87(1):5-12. DOI: https://doi.org/10.1016/j.acmx.2016.11.003; Gómez-Doblas JJ, López-Garrido MA, Esteve-Ruiz I, Barón-Esquivias G. Epidemiología de la fibrilación auricular. Rev Española Cardiol (Supl). 2016 [acceso 15/05/2022];16:2-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S1131358716300073; Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI: https://doi.org/10.1093/eurheartj/ehw210; Forero-Gómez JE, Moreno JM, Agudelo CA, Rodríguez-Arias EA, Sánchez-Moscoso PA. Fibrilación auricular: enfoque para el médico no cardiólogo. Iatreia. 2017 [acceso 15/05/2022];30(4):404-22. Disponible en: http://www.scielo.org.co/pdf/iat/v30n4/0121-0793-iat-30-04-00404.pdf; Verma K, Wong M. Atrial fibrillation. Aust J Gen Pract. 2019 [acceso 15/05/2022];20(48):694-9. Disponible en: https://www1.racgp.org.au/ajgp/2019/october/atrial-fibrillation; Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105(24):1860-7. DOI: https://doi.org/10.1136/heartjnl-2018-314267; Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017;40(6):413-8. DOI: https://doi.org/10.1002/clc.22667; Quintero-González JA. Cincuenta años de uso clínico de la warfarina. Investigación Clínica. 2010 [acceso 15/05/2022];51(2):269-87. Disponible en: http://ve.scielo.org/pdf/ic/v51n2/art08.pdf; Oviedo Pérez KJ, Arce Arguedas EJ, García Vásquez ML. Warfarina versus inhibidores del factor X en pacientes con fibrilación atrial como tratamiento para evitar complicaciones. Rev Fac Med Univ lberoamérica. 2021 [acceso 15/05/2022];3(2). Disponible en: http://www.unibe.ac.cr/ojs/index.php/RFMUI/article/view/71/100; Lip GYH, Freedman B, De Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: past, present and future. Thromb Haemost. 2017;117(7):1230-9. DOI: https://doi.org/10.1160/th16-11-0876; Kotecha D, Bunting K V, Gill SK, Mehta S, Stanbury M, Jones JC, et al. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. JAMA. 2020 [acceso 18/05/2022];324(24):2497-508. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33351042; Scalese MJ, Salvatore DJ. Role of Digoxin in Atrial Fibrillation. J Pharm Pract. 2017;30(4):434-40. DOI: https://doi.org/10.1177/0897190016642361; Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, et al. Digoxin and Mortality in Patients with Atrial Fibrillation. J Am Coll Cardiol. 2018 [acceso 18/05/2022];71(10):1063-74. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109718301037; Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020 [acceso 18/05/2022];106(1):10-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31533990; Migdady I, Russman A, Buletko AB. Atrial Fibrillation and Ischemic Stroke: A Clinical Review. Semin Neurol. 2021;41(4):348-64. DOI: https://doi.org/10.1055/s-0041-1726332; Boursier-Bossy V, Zuber M, Emmerich J. Ischemic stroke and non-valvular atrial fibrillation: When to introduce anticoagulant therapy? JMV-Journal Med Vasc. 2020;45(2):72-80. DOI: https://doi.org/10.1016/j.jdmv.2020.01.153; Healey JS, Amit G, Field TS. Atrial fibrillation and stroke: How much atrial fibrillation is enough to cause a stroke? Curr Opin Neurol. 2020;33(1):17-23. DOI: https://doi.org/10.1097/wco.0000000000000780; Katsanos AH, Kamel H, Healey JS, Hart RG. Stroke Prevention in Atrial Fibrillation. Circulation. 2020;142(24):2371-88. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.049768; Kirchhof P, Breithardt G, Bax J, Benninger G, Fetsch T, Freedman S Ben, et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the Fifth Atrial Fibrillation Network/European Heart Rhythm Association Consensus Conference. EP Europace. 2016;18(1):37-50. DOI: https://doi.org/10.1093/europace/euv304; Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation. Chest. 2010 [acceso 18/05/2022];137(2):263-72. Disponible en: https://www.sciencedirect.com/science/article/pii/S0012369210600670; Al-Alusi MA, Ding E, McManus DD, Lubitz SA. Wearing Your Heart on Your Sleeve: the Future of Cardiac Rhythm Monitoring. Curr Cardiol Rep. 2019 [acceso 19/05/2022];21(12):158. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31768764; Lambert CT, Patel D, Bumgarner JM, Kanj M, Cantillon D, Saliba W, et al. Atrial fibrillation future clinic. Novel platform to integrate smart device electrocardiogram into clinical practice. Cardiovasc Digit Heal J. 2021;2(2):92-100. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S2666693621000220; National Institute for Health and Care Excellence (NICE). KardiaMobile for detecting atrial fibrillation. London; 2022. Disponible en: https://www.nice.org.uk/guidance/mtg64; National Institute for Health and Care Excellence (NICE). Atrial fibrillation: diagnosis and management NICE guideline. NICE Guideline. London; 2021. Disponible en: www.nice.org.uk/guidance/ng196; Zaprutko T, Zaprutko J, Sprawka J, Pogodzińska M, Michalak M, Paczkowska A, et al. The comparison of Kardia Mobile and Hartmann Veroval 2 in 1 in detecting first diagnosed atrial fibrillation. Cardiol J. 2021:1-9. DOI: https://doi.org/10.5603/cj.a2021.0083; Koltowski L, Balsam P, Glowczynska R, Rokicki JK, Peller M, Maksym J, et al. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center. Cardiol J. 2021 [acceso 19/05/2022];28(4):543-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30644079; Murad MH. Clinical Practice Guidelines: A Primer on Development and Dissemination. Mayo Clin Proc. 2017;92(3):423-33. DOI: http://dx.doi.org/10.1016/j.mayocp.2017.01.001; Brieger D, Amerena J, Attia JR, Bajorek B, Chan KH, Connell C, et al. National heart foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Med J Aust. 2018;209(8):356-62. DOI: https://doi.org/10.1016/j.hlc.2018.06.1043; Soto-Becerra R, Zafra-Tanaka JH, Goicochea-Lugo S, Alarcón-Ruiz CA, Pacheco-Barrios K, Taype-Rondan A, et al. Guía de práctica clínica para el manejo de pacientes con fibrilación auricular en el Seguro Social del Perú (EsSalud). An la Fac Med. 2019 [acceso 19/05/2022];80(2):250-63. Disponible en: http://www.scielo.org.pe/pdf/afm/v80n2/a21v80n2.pdf; Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol. 2021 [acceso 19/05/2022];74(5): e1-437. Disponible en: https://www.revespcardiol.org/es-pdf-S0300893220306953; Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: A practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):1-18. DOI: https://doi.org/10.1161/jaha.120.017559; De Luca L, Mistrulli R, Veneziano FA, Grigioni F, Volpe M, Musumeci F, et al. Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. J Clin Med. 2022 [acceso 19/05/2022];11(3):512. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35159964; Stacy ZA, Richter SK. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations. Ther Adv Cardiovasc Dis. 2018 [acceso 20/05/2022];12(9):247-62. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30081727; Brízido C, Ferreira AM, Lopes P, Strong C, Mendes GS, Gama FF, et al. Adesão à terapêutica com anticoagulantes diretos em doentes com fibrilhação auricular não valvular – uma análise de mundo real. Rev Port Cardiol. 2021 [acceso 20/05/2022];40(9):669-75. Disponible en: https://www.sciencedirect.com/science/article/pii/S0870255121001955; Ramírez-Prieto G, Pombo-Bartelt JE, Rojas-Calderón G, García-González JJ. Prescription of oral anticoagulation in geriatric patients with atrial fibrillation. Arch Cardiol Mex. 2022 [acceso 20/05/2022];92(1):42-52. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34153976; Roberti R, Iannone LF, Palleria C, Curcio A, Rossi M, Sciacqua A, et al. Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice. Front Pharmacol. 2021;12(5):1-14. DOI: https://doi.org/10.3389/fphar.2021.684638; Cosin-Sales J, Olalla J. Tratamiento farmacológico de la fibrilación auricular. Antiarrítmicos y anticoagulantes orales. Rev Esp Cardiol. 2016;16(Supl):33-9. DOI: https://doi.org/10.1016/S1131-3587(16)30012-7; Akel T, Lafferty J. Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis. Ann Noninvasive Electrocardiol. 2018;23(3):1-7. DOI: https://doi.org/10.1111/anec.12508; Markey GC, Salter N, Ryan J. Intravenous Flecainide for Emergency Department Management of Acute Atrial Fibrillation. J Emerg Med. 2018;54(3):320-7. DOI: https://doi.org/10.1016/j.jemermed.2017.11.016; Müssigbrodt A, John S, Kosiuk J, Richter S, Hindricks G, Bollmann A. Vernakalant-facilitated electrical cardioversion: Comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion. Europace. 2015;18(1):51-6. DOI: https://doi.org/10.1093/europace/euv194; Um KJ, McIntyre WF, Healey JS, Mendoza PA, Koziarz A, Amit G, et al. Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: A systematic review and meta-analysis. Europace. 2019;21(6):856-63. DOI: https://doi.org/10.1093/europace/euy310; Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, et al. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. Am J Cardiol. 2013;111(2):225-30. DOI: http://dx.doi.org/10.1016/j.amjcard.2012.09.020; Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythmia Electrophysiol. 2019;12(9):1-13. DOI: https://doi.org/10.1161/circep.119.007414; Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: A multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501-7. DOI: https://doi.org/10.1093/eurheartj/eht457; Nimjee SM, White RR, Becker RC, Sullenger BA. Aptamers as Therapeutics. Annu Rev Pharmacol Toxicol. 2017 [acceso 20/05/2022];57:61-79. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28061688; Chabata CV, Frederiksen JW, Sullenger BA, Gunaratne R. Emerging applications of aptamers for anticoagulation and hemostasis. Curr Opin Hematol. 2018 [acceso 20/05/2022];25(5):382-8. Disponible en: https://journals.lww.com/co-hematology/Fulltext/2018/09000/Emerging_applications_of_aptamers_for.6.aspx; Rocca ML, Palumbo AR, Visconti F, Di Carlo C. Safety and benefits of contraceptives implants: A systematic review. Pharmaceuticals. 2021;14(6):1-26. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229462/; Teal S, Edelman A. Contraception Selection, Effectiveness, and Adverse Effects. JAMA. 2021 [acceso 20/05/2022];326(24):2507. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2787541; https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1391

  20. 20
    Academic Journal